Letter to the Editor: The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer. Uygur A, Sayili U. J Med Virol 2023 Mar 11. doi: 10.1002/jmv.28664.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Uygur A, Sayili U. Letter to the Editor: The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer. J Med Virol 2023 Mar 11. doi: 10.1002/jmv.28664.
PMID: 36905217